These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12050573)

  • 1. Lymphoproliferation in children after liver transplantation.
    Smets F; Sokal EM
    J Pediatr Gastroenterol Nutr; 2002 May; 34(5):499-505. PubMed ID: 12050573
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-Transplantation Lymphoproliferative Disorders in Adults.
    Dierickx D; Habermann TM
    N Engl J Med; 2018 Feb; 378(6):549-562. PubMed ID: 29414277
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus DNA monitoring in serum and whole blood in pediatric liver transplant recipients who do or do not discontinue immunosuppressive therapy.
    Kullberg-Lindh C; Saalman R; Olausson M; Herlenius G; Lindh M
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28039929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Posttransplant lymphoproliferative disorder].
    Oike F; Egawa H; Haga H; Kudo T
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():639-46. PubMed ID: 16615551
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder.
    Bar-Natan M; Nagler A
    Isr Med Assoc J; 2006 Mar; 8(3):205-7. PubMed ID: 16599060
    [No Abstract]   [Full Text] [Related]  

  • 6. Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation.
    Cao S; Cox K; Esquivel CO; Berquist W; Concepcion W; Ojogho O; Monge H; Krams S; Martinez O; So S
    Transplantation; 1998 Oct; 66(7):851-6. PubMed ID: 9798693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines.
    Styczynski J; van der Velden W; Fox CP; Engelhard D; de la Camara R; Cordonnier C; Ljungman P;
    Haematologica; 2016 Jul; 101(7):803-11. PubMed ID: 27365460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders.
    Gross TG
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):7-9. PubMed ID: 11196278
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary central nervous system posttransplantation lymphoproliferative disorder after heart and lung transplantation.
    Gifford G; Fay K; Jabbour A; Ma DD
    Intern Med J; 2015 May; 45(5):583-6. PubMed ID: 25955465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent detection of Epstein-Barr virus DNA after pediatric liver transplantation: unclear risks and uncertain responses.
    Green M; Mazariegos GV
    Liver Transpl; 2008 Aug; 14(8):1077-80. PubMed ID: 18668662
    [No Abstract]   [Full Text] [Related]  

  • 11. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease.
    Smets F; Latinne D; Bazin H; Reding R; Otte JB; Buts JP; Sokal EM
    Transplantation; 2002 May; 73(10):1603-10. PubMed ID: 12042647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of posttransplant lymphoproliferative disorder with removal of small bowel graft and subsequent second bowel transplant.
    Talisetti A; Testa G; Holterman M; John E; Kecskes S; Benedetti E
    J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):354-6. PubMed ID: 16131994
    [No Abstract]   [Full Text] [Related]  

  • 14. Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?
    Dierickx D; Cardinaels N
    World J Gastroenterol; 2015 Oct; 21(39):11034-43. PubMed ID: 26494960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of post-transplant lymphoproliferative disorders.
    DeStefano CB; Desai SH; Shenoy AG; Catlett JP
    Br J Haematol; 2018 Aug; 182(3):330-343. PubMed ID: 29741774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant lymphoproliferative disorder and tonsillectomy in a pediatric liver transplant population.
    Nalesnik MA
    Liver Transpl; 2001 May; 7(5):466-8. PubMed ID: 11349270
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathology forum: quiz case 1. Diagnosis: posttransplant lymphoproliferative disease (PTLD) of the epiglottis.
    Rosbe KW; Perez-Atayde AR; Roberson DW; Kenna M
    Arch Otolaryngol Head Neck Surg; 2000 Sep; 126(9):1153; discussion 1157-8. PubMed ID: 10979133
    [No Abstract]   [Full Text] [Related]  

  • 18. Post-transplant lymphoproliferative disorders: from treatment to early detection and prevention?
    Bakker NA; van Imhoff GW
    Haematologica; 2007 Nov; 92(11):1447-50. PubMed ID: 18024391
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary ocular posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    O'Connor JA; Lin JC; Cordle RA; Lloyd WC; Lillis PK; O'Hara M
    J Pediatr Gastroenterol Nutr; 2001 Jan; 32(1):89-91. PubMed ID: 11176333
    [No Abstract]   [Full Text] [Related]  

  • 20. Epstein-Barr virus infection after pediatric living-related liver transplantation--management and risk factors.
    Shigeta T; Imadome K; Sakamoto S; Fukuda A; Kakiuchi T; Matsuno N; Tanaka H; Nakazawa A; Kasahara M
    Transplant Proc; 2010 Dec; 42(10):4178-80. PubMed ID: 21168657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.